Results 91 to 100 of about 43,146 (238)

Gross motor performance of infants with an at‐home wearable measurement and the Alberta Infant Motor Scale: A concurrent validity study

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To evaluate the concurrent validity of assessing infants' gross motor performance with an at‐home wearable measurement versus the Alberta Infant Motor Scale (AIMS). Method This observational study used a new multi‐sensor wearable Motor Assessment of Infants with a JUmpsuit (MAIJU) for 67 at‐home measurements of 42 infants (60% males; mean ...
Manu Airaksinen, Taru Palsa, Arto Hautala, Marike Boonzaaijer, Leena M. Haataja, Sampsa Vanhatalo   +5 more
wiley   +1 more source

Early neurodevelopmental outcome in newborns with mild hypoxic‐ischaemic encephalopathy

Developmental Medicine &Child Neurology, EarlyView.
Aim To describe the natural history of newborn children with mild hypoxic‐ischaemic encephalopathy in the first year of life. Method This was a multicentre, prospective observational study involving five neonatal intensive care units in an Italian region using both structured clinical and neurophysiological assessments according to the Italian Society ...
Domenico M. Romeo, Chiara Arpaia, Angelo Di Malta, Elisa Pede, Grazia Maria Cicala, Daniela Ricci, Francesca Serrao, Eugenio Mercuri, Claudia Brogna, Mild Encephalopathy Regional Network*, Giovanni Vento, Chiara Cafforio, Eleonora Scapillati, Roberta Arena, Francesca Gallini, Vita Augusta, Andrea Guzzetta   +16 more
wiley   +1 more source

Epidemiology of cerebral palsy in Brazil through the lens of the International Classification of Functioning, Disability and Health framework

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To establish an overall description of people with cerebral palsy (CP) in Brazil, including the epidemiology, clinical features, functioning, and access to rehabilitation and equipment, through the lens of the International Classification of Functioning, Disability and Health (ICF) framework, using preliminary data from the Brazilian ...
Hércules Ribeiro Leite, Luana Cristina da Silva, Elton Duarte Dantas Magalhães, Israt Jahan, Nadia Badawi, Gulam Khandaker, Maysa Ferreira Martins Ribeiro, Juliana de Alcântara Moreira Pereira, Luma Sthephanine Viana Roque da Silva, Maria de las Mercedes Ruiz Brunner, Paula Silva de Carvalho Chagas   +10 more
wiley   +1 more source

Clinical and genetic characterization of intellectual disability

Developmental Medicine &Child Neurology, EarlyView.
This study examines the etiological factors and comorbidities in a large cohort of Finnish patients with intellectual disability. Genetic causes—including chromosomal abnormalities and pathogenic gene variants—were more frequently identified in individuals with moderate to profound intellectual disability.
Aarni Venetvaara, Minna Kraatari‐Tiri, Jussi‐Pekka Tolonen, Marko Merikukka, IDGEN Study Group, Hannaleena Kokkonen, Teija Paakkola, Susanna Varis, Antti Dahl, Jarmo Körkkö, Jonna Komulainen‐Ebrahim, Jukka Moilanen, Johanna Uusimaa, Outi Kuismin, Elisa Rahikkala   +14 more
wiley   +1 more source

Spectral Characterization of the Life Stages and Physiological Responses of Diatraea saccharalis Fabricius (Lepidoptera: Crambidae) Larvae Parasitized by Cotesia flavipes Cameron (Hymenoptera: Braconidae)

Entomologia Experimentalis et Applicata, EarlyView.
Hyperspectral proximal sensing was used to characterize the life stages and physiological responses of Diatraea saccharalis and to detect parasitism by Cotesia flavipes. Distinct spectral signatures differentiated eggs, larval instars, pupae, and adults, as well as live, dead, and parasitized larvae.
Souradji I. Bachirou, David L. Rosalen, Sergio A. De Bortoli, Pedro G. Peixoto   +3 more
wiley   +1 more source

Urgent need for services to support children with and at risk of developmental disabilities in low‐ and middle‐income countries

Developmental Medicine &Child Neurology, EarlyView.
Nathaniel Scherer, Cally J Tann, Hannah Kuper   +2 more
wiley   +1 more source

Congenital bilateral laryngeal paralysis in a neonatal foal—Expanding our understanding of neonatal airway dysfunction

Equine Veterinary Education, EarlyView.
Summary The case report by De Maré et al. 2025 describes a rare but instructive case of bilateral laryngeal paralysis in a newborn Warmblood foal with suspected neonatal encephalopathy (NE). The foal presented with inspiratory stridor from birth and was successfully managed through supportive medical therapy and temporary nasotracheal intubation, with ...
M. Abraham
wiley   +1 more source

Detection of neonatal asphyxia by analyzing the complexity of electroencephalography data

Frontiers in Applied Mathematics and Statistics
IntroductionIn neonates, the early detection of asphyxia improves survival rates and prevents long-term complications. In neonatal care, physiological signals, including heart rate and oxygen saturation, are routinely monitored.
Sou Nobukawa, Sou Nobukawa, Sou Nobukawa, Sou Nobukawa, Kurnianingsih, Isshu Wakita, Ayumu Ueno, Melyana Nurul Widyawati, Cipta Pramana, Nurseno Bayu Aji, Afandi Nur Aziz Thohari, Dwiana Hendrawati, Eri Sato-Shimokawara, Naoyuki Kubota   +13 more
doaj   +1 more source

Incidents of sudden death during restraint of agitated individuals in Sweden between 1992 and 2024. [PDF]

J Forensic Sci
Abstract Restraint‐related sudden deaths in agitated individuals raise complex questions at the intersection of medicine and law. Hyperactive delirium with extreme agitation as well as positional asphyxia due to restraint have been proposed to account for these deaths. However, the exact physiological mechanisms responsible and to what extent restraint
Tyr A, Lindeman E, Tamsen F, Thiblin I, Zilg B.   +4 more
europepmc   +2 more sources

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin, Marie Tauber, Robert Sidbury, Jonathan I. Silverberg, Kim A. Papp, Diamant Thaçi, Marjolein S. De Bruin‐Weller, Adam Reich, Ketty Peris, Kirk Barber, Ryszard Galus, Andrzej Kaszuba, Matthew Zirwas, Walter K. Nahm, Gretel Trullenque, Laura Maintz, Sady Alpizar, Sang Wook Son, Vivian Laquer, Linda Stein Gold, Soo Yeon Cheong, Anna Ryzhkova, Agnes Drahos, Liliana Ulianov, Christophe Piketty   +24 more
wiley   +1 more source